Welcome

Sign out Have a question? We're here to help

Copyright © 2019 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Genmab A/S (GMAB)

$21.05 0.07 (0.33%)

16:00 EDT GMAB Stock Quote Delayed 15 Minutes

Volume:

Previous Close $21.05

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 146,500

Day's Range 20.90 - 21.10

52-Week Range 17.72 - 21.45

Dividend & Yield N/A (N/A)

GMAB Stock Predictions, Articles, and Genmab A/S News

From InvestorPlace
From the Web

10 Great Biotech Stocks to Buy in Q4

By Sarah Smith, InvestorPlace Web Editor Oct 7, 2019

With FDA Breakthrough Therapy designations and robust drug pipelines, these biotech companies are all stocks to buy for 2020.

14 Healthcare Stocks Moving In Thursday's Pre-Market Session

From Benzinga Oct 17, 2019

Gainers Hepion Pharmaceuticals, Inc. (NASDAQ: HEPA) shares increased by 86.0% to $4.65 during Thursday's pre-market session. The market cap seems to be at $9.3 million....

10 Biggest Price Target Changes For Wednesday

From Benzinga Oct 16, 2019

KeyBanc cut the price target for Alibaba Group Holding Ltd - ADR (NYSE: BABA) from $245 to $243. Alibaba shares closed at $175.29 on Tuesday. Wedbush raised Docusign Inc (...

Best & Worst Performing Mid Cap Stocks for October 15, 2019

From StockNews.com Oct 15, 2019

RETA – RETA leads the way today as the best performing mid cap stock, closing up 56.99%.

Best & Worst Performing Mid Cap Stocks for October 14, 2019

From StockNews.com Oct 14, 2019

ACM – ACM leads the way today as the best performing mid cap stock, closing up 6.30%.

Best & Worst Performing Mid Cap Stocks for October 10, 2019

From StockNews.com Oct 10, 2019

RARX – RARX leads the way today as the best performing mid cap stock, closing up 101.15%.

BioNTech IPO: What You Need To Know

From Benzinga Oct 8, 2019

An oncology biotech that promises individualized immunotherapies is part of the slate for the week. The IPO Terms Germany-based BioNTecg SE is proposing to offer 13.2 million ADSs...

Navellier Ratings

Powered by Portfolio Grader

Total Grade

B

Buy

Free Report

10 Stocks Set for Monster Growth

He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!

Download your FREE COPY!